Sign in

CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
841475642
Phone
(346) 355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale EVP, Operations sold 20,132 shares at $1.27 ($25,568)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.40 ($14,000)
  9. 4 Open-market buy Director bought 100,000 shares at $1.91 ($191,000)
  10. 4 Open-market buy Director bought 23,770 shares at $1.76 ($41,835)
  11. 4 Open-market buy Director bought 50,000 shares at $1.83 ($91,500)
  12. 4 Open-market buy Director bought 75,000 shares at $1.73 ($129,750)
  13. 4 Open-market buy Director bought 100,000 shares at $1.71 ($171,000)
  14. 4 Grant or award Chief Executive Officer acquired 875,000 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Medical Officer acquired 80,645 shares (grant or award)
  17. 4 Grant or award Director acquired 4,167 shares (grant or award)
  18. 4 Grant or award Director acquired 4,167 shares (grant or award)
  19. 4 Grant or award Director acquired 5,000 shares (grant or award)
  20. 4 Grant or award Director acquired 2,500 shares (grant or award)

Page 5 of 24 · 465 filings